Your browser doesn't support javascript.
loading
The H89 cAMP-dependent protein kinase inhibitor blocks Plasmodium falciparum development in infected erythrocytes.
Syin, C; Parzy, D; Traincard, F; Boccaccio, I; Joshi, M B; Lin, D T; Yang, X M; Assemat, K; Doerig, C; Langsley, G.
Affiliation
  • Syin C; Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD, USA.
Eur J Biochem ; 268(18): 4842-9, 2001 Sep.
Article in En | MEDLINE | ID: mdl-11559352
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Plasmodium falciparum / Sulfonamides / Cyclic AMP-Dependent Protein Kinases / Enzyme Inhibitors / Erythrocytes / Isoquinolines Limits: Animals / Humans Language: En Journal: Eur J Biochem Year: 2001 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Plasmodium falciparum / Sulfonamides / Cyclic AMP-Dependent Protein Kinases / Enzyme Inhibitors / Erythrocytes / Isoquinolines Limits: Animals / Humans Language: En Journal: Eur J Biochem Year: 2001 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido